The composition of the vaccine, kit of parts, pharmaceutical composition, process for the manufacture of a vaccine composition, methods for treating a patient suffering from, or susceptu00ecvel a tumor, infectious disease and allergy, to increase an immune response of a mamu00ecfero to antu00ecgeno and C Against a disease state.To improve the treatment of a patient with C u00e1 NCER and improve effectively cytotoxicity of cytotoxic drugs or radiotherapy, and the use of derivative of proteu00ecna purified

摘要

The composition of the vaccine, kit of parts, pharmaceutical composition, process for the manufacture of a vaccine composition, methods for treating a patient suffering from, or susceptu00ecvel a tumor, infectious disease and allergy, to increase an immune response of a mamu00ecfero for a antu00ecge In and against a disease state.To improve the treatment of a patient with C u00e1 NCER and improve efficacy of cytotoxic drugs or radiotherapy, cytotoxic, and use of derivative of proteu00ecna purified. The present invention provides a new adjuvant vaccine of nucleic acids, and in particular, the present invention provides nucleic acid vaccines that comprise, or are administered in combination with PPD.The present invention also provides methods to improve the therapeutic efficacy of vaccine of nucleic acids.